XOOMAR

Tonix Pharmaceuticals Holding (TNXP)

Tonix Pharmaceuticals Holding on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

2.9M

Short interest

settlement 2026-09-30

5.9

Days to cover

-2.2 days vs prior

64.1%

Short share of volume

2026-10-23

202

Fails to deliver

settlement 2026-09-30

Tue 2 Feb

Next earnings

estimated date

$40K

Insider flow, 90 days

2 buys, 0 sells

As of 2026-10-23.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in TNXP is 2,937,499 shares, down 164,517 shares over the last month. Over the last 48 readings it ranged from 333,835 shares (14 February 2025) to 15,925,228 shares (15 January 2025). At the reported average volume of 498K shares a day that is 5.9 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/tnxp" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-09-302,937,499+3.5%497,6905.90
2026-09-152,838,419-8.5%348,8778.14
2026-08-313,102,016-9.0%486,6626.37
2026-08-143,408,130-5.4%490,6616.95
2026-07-313,601,417+0.5%500,4297.20
2026-07-153,584,541+0.1%495,9387.23
2026-06-303,582,293+16.2%586,9076.10
2026-06-153,081,836+7.5%615,3845.01
2026-05-292,867,066+22.4%460,9366.22
2026-05-152,342,643-10.2%461,1245.08
2026-04-302,607,374+5.3%326,6007.98
2026-04-152,476,401+19.3%453,4455.46
2026-03-312,075,650-16.1%563,3313.68
2026-03-132,473,177+17.5%303,2538.16
2026-02-272,104,214-10.7%322,1906.53
2026-02-132,355,361+0.9%313,1287.52
2026-01-302,333,492+7.5%429,9715.43
2026-01-152,171,198-6.3%473,3694.59
2025-12-312,316,682+4.5%494,3094.69
2025-12-152,216,942+9.7%549,6194.03
2025-11-282,020,733+3.9%1,005,4662.01
2025-11-141,944,721+6.0%623,9353.12
2025-10-311,835,052+2.8%661,0072.78
2025-10-151,785,053-7.5%1,017,6981.75
2025-09-301,930,715+45.0%1,184,2161.63
2025-09-151,331,960+13.5%1,247,2951.07
2025-08-291,173,859-12.9%1,978,5871.00
2025-08-151,347,517+11.7%1,873,4531.00
2025-07-311,206,311+1.5%1,772,8271.00
2025-07-151,188,503-1.7%789,9111.50
2025-06-301,209,305+7.0%689,5191.75
2025-06-131,129,784+7.0%770,7331.47
2025-05-301,056,374+16.3%2,016,5241.00
2025-05-15908,353-7.0%634,8431.43
2025-04-30976,171-13.0%585,4131.67
2025-04-151,121,764+21.9%936,9271.20
2025-03-31919,908+4.7%2,324,0721.00
2025-03-14878,522+59.4%2,627,2391.00
2025-02-28551,259+65.1%536,8711.03
2025-02-14333,835-96.6%2,316,6461.00
2025-01-319,730,922-38.9%135,619,7921.00
2025-01-1515,925,228+104.7%68,151,1511.00
2024-12-317,781,745+94.6%380,376,6961.00
2024-12-133,999,258+151.5%37,555,3421.00
2024-11-291,590,312-69.5%110,099,6651.00
2024-11-155,221,229-31.9%11,416,0311.00
2024-10-317,670,373+40.4%25,529,9481.00
2024-10-155,463,201-34.1%16,354,5551.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 23 October 2026, the short share of TNXP volume is 64.1%, up 8.3 points over the last five sessions. Over the last 30 readings it ranged from 29.1% (14 September 2026) to 74.5% (15 October 2026). The latest reading is 8.3 points above the 30-session average of 55.8%, on 362K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-10-23232K362K64.1%0
2026-10-22223K389K57.4%0
2026-10-21254K397K64.1%418
2026-10-20222K344K64.5%4,597
2026-10-19301K593K50.8%308
2026-10-16238K425K55.8%24,837
2026-10-15636K854K74.5%7,076
2026-10-14449K774K58.1%1,099
2026-10-13332K597K55.6%406
2026-10-12255K471K54.2%4,443
2026-10-09306K415K73.7%1,200
2026-10-08221K507K43.5%2
2026-10-07135K276K48.9%0
2026-10-06508K1.5M32.9%59,841
2026-10-05364K645K56.3%6,758
2026-10-02268K406K66.0%1,775
2026-10-01146K216K67.7%0
2026-09-3055K108K50.9%0
2026-09-2970K174K40.4%0
2026-09-2898K157K62.3%180
2026-09-25117K170K69.1%0
2026-09-24180K293K61.7%1,130
2026-09-23200K475K42.1%7,759
2026-09-22115K267K43.2%9,854
2026-09-21114K235K48.4%100
2026-09-1883K161K51.3%0
2026-09-17119K184K64.7%0
2026-09-1680K120K66.6%0
2026-09-1566K114K57.7%0
2026-09-1479K273K29.1%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 30 September 2026, the fails-to-deliver balance in TNXP is 202 shares, down 674 shares over the last settlement date. Over the last 30 readings it ranged from 15 shares (17 July 2026) to 24,705 shares (21 August 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-09-30202$9.65$2K
2026-09-28876$9.86$9K
2026-09-251,908$9.70$19K
2026-09-11100$12.28$1K
2026-09-081,977$13.14$26K
2026-09-023,167$13.98$44K
2026-08-3157$13.59$775
2026-08-27848$13.64$12K
2026-08-26429$13.66$6K
2026-08-2124,705$12.39$306K
2026-08-2088$12.73$1K
2026-08-1960$12.66$760
2026-08-1725$12.71$318
2026-08-1328$11.97$335
2026-08-11850$12.59$11K
2026-08-104,509$12.03$54K
2026-08-07150$11.65$2K
2026-08-06650$11.26$7K
2026-08-0498$10.67$1K
2026-08-03436$10.01$4K
2026-07-311,170$10.09$12K
2026-07-221,340$11.56$15K
2026-07-1715$11.85$178
2026-07-07255$12.71$3K
2026-07-02524$12.44$7K
2026-06-304,428$12.75$56K
2026-06-296,347$13.22$84K
2026-06-264,735$11.98$57K
2026-06-251,756$12.10$21K
2026-06-1772$11.63$837

Insider trades

SEC Form 4, newest first. JSON

Insiders at TNXP reported 2 open-market buys worth $40K in the last 90 days and no open-market sells. Latest filing: LEDERMAN SETH (Chief Executive Officer) on 2026-08-27.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-08-27LEDERMAN SETHChief Executive OfficerBuy2K$13.79$28K11K
2026-08-20BAGGER RICHARD HDirectorBuy1K$12.60$13K1K
2026-06-30SAENGER BRADLEYChief Financial OfficerOther transaction1K$10.91$16K2K
2026-06-12Taylor Carolyn E.DirectorBuy1K$10.55$15K2K
2026-06-09LEDERMAN SETHChief Executive OfficerBuy5K$11.79$59K9K
2026-06-08Stillwell Richard NewcombDirectorBuy5K$11.65$58K5K
2026-03-31LEDERMAN SETHChief Executive OfficerBuy5K$12.62$63K20K
2026-03-18LEDERMAN SETHChief Executive OfficerBuy15K$14.89$223K15K
2025-08-21Taylor Carolyn E.DirectorBuy418$36.03$15K418
2025-08-20Treco JamesDirectorBuy250$36.00$9K250
2025-05-15LEDERMAN SETHChief Executive OfficerBuy4K$21.55$86K4K
2025-02-05MORRIS JESSICA EDGARChief Operating OfficerOther transaction1$0.00$00
2025-02-05LEDERMAN SETHChief Executive OfficerOther transaction0$3.30$11
2025-02-05LEDERMAN SETHChief Executive OfficerOther transaction5$3.38$185
2025-02-05LEDERMAN SETHChief Executive OfficerOther transaction1$0.15$00
2025-02-05SULLIVAN GREGORY MChief Medical OfficerOther transaction0$1.47$00
2025-02-05SAENGER BRADLEYChief Financial OfficerOther transaction0$0.00$00
2025-02-05BAGGER RICHARD HDirectorOther transaction0$0.20$00
2025-02-05Treco JamesDirectorOther transaction0$0.30$00
2025-02-05Bell Margaret SmithDirectorOther transaction1$0.15$00
2024-06-10OLUKOTUN ADEOYE YDirectorOther transaction1$1.91$20
2022-06-29LEDERMAN SETHChief Executive OfficerBuy20K$1.71$34K24K
2022-03-25LEDERMAN SETHChief Executive OfficerBuy100K$0.25$25K112K
2021-09-28LEDERMAN SETHChief Executive OfficerBuy12K$0.61$7K12K
2021-05-25Goodman Daniel WintnerDirectorBuy5K$1.12$6K5K
2021-03-24LEDERMAN SETHChief Executive OfficerBuy17K$1.32$22K135K
2021-01-07SULLIVAN GREGORY MChief Medical OfficerGrant41K$0.51$21K63K
2020-12-30LEDERMAN SETHChief Executive OfficerBuy35K$0.68$24K118K
2020-08-31Treco JamesDirectorBuy6K$0.89$5K10K
2020-08-20Bell Margaret SmithDirectorBuy5K$0.93$5K5K
2020-08-17SULLIVAN GREGORY MChief Medical OfficerBuy20K$1.03$21K21K
2020-08-14Treco JamesDirectorBuy5K$1.06$5K5K
2020-08-13BAGGER RICHARD HDirectorBuy10K$0.91$9K10K
2020-08-13LEDERMAN SETHChief Executive OfficerBuy60K$0.91$55K83K
2020-08-13OLUKOTUN ADEOYE YDirectorBuy5K$0.94$5K5K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

9 holders report 5% or more of TNXP in their latest filing, all on Schedule 13G (passive). The largest reported stake is Point72 Asset Management, L.P. at 6.9% of the class (1,100,964 shares), filed 2026-05-15 for an event on 2026-03-31.

FiledFormHolderSharesOf classEvent
2026-08-1413G/Ano. 1Sirenia Capital Management LPinvestment adviser, partnership815K4.9%2026-06-30
2026-08-1413G/Ano. 1Alex Silversteinparent holding company, individual815K4.9%2026-06-30
2026-08-1313GAQR Capital Management, LLCinvestment adviser883K5.5%2026-06-30
2026-08-1313GAQR Capital Management Holdings, LLCparent holding company883K5.5%2026-06-30
2026-06-1513GMillennium Management LLCother entity890K5.6%2026-06-09
2026-06-1513GMillennium Group Management LLCother entity890K5.6%2026-06-09
2026-06-1513GIsrael A. Englanderindividual890K5.6%2026-06-09
2026-05-1513G/Ano. 1Point72 Asset Management, L.P.partnership1.1M6.9%2026-03-31
2026-05-1513G/Ano. 1Point72 Capital Advisors, Inc.corporation1.1M6.9%2026-03-31
2026-05-1513G/Ano. 1Steven A. Cohenindividual1.1M6.9%2026-03-31
2026-03-2713G/Ano. 2The Vanguard Groupinvestment adviser00.0%2026-03-13
2026-01-2113G/Ano. 2BlackRock, Inc.parent holding company855K6.7%2025-12-31

13F holders

Tracked managers holding TNXP at their latest 13F. JSON

5 of the 30 tracked managers held TNXP at their latest 13F, $41.4M in total at quarter-end prices. Point72 Asset Management is the largest at $14.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 1 cut.

FundQuarterSharesValueOf portfolioChange in shares
Point72 Asset Management2026-06-301.2M$14.9M0.02%+1.0M
Millennium Management2026-06-30967K$12.3M0.00%+747K
AQR Capital Management2026-06-30883K$11.3M0.00%+721K
Citadel Advisors2026-06-30196K$2.5M0.00%-273K
Two Sigma Investments2026-06-3029K$368K0.00%new

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Tonix Pharmaceuticals Holding in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Tonix Pharmaceuticals Holding (TNXP), SEC CIK 1430306, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-10-15.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-27.JSON and CSV
Company record
EDGAR filing index for CIK 1430306Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of TNXP is sold short?
2,937,499 shares were held short at the 2026-09-30 settlement, 5.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is TNXP's daily short volume?
On 2026-10-23, 232,337 of the 362,201 TNXP shares reported to FINRA were sold short, 64.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does TNXP have fails to deliver?
The SEC's latest file shows 202 TNXP shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.
Are TNXP insiders buying or selling?
Insiders at TNXP reported 2 open-market buys worth $40K in the last 90 days and no open-market sells. Latest filing: LEDERMAN SETH (Chief Executive Officer) on 2026-08-27.
Who owns 5% or more of TNXP?
9 holders report 5% or more of TNXP in their latest filing, all on Schedule 13G (passive). The largest reported stake is Point72 Asset Management, L.P. at 6.9% of the class (1,100,964 shares), filed 2026-05-15 for an event on 2026-03-31.
Which tracked 13F managers own TNXP?
5 of the 30 tracked 13F managers held TNXP shares at their latest filing, $41.4M in all. The largest: Steve Cohen's Point72 Asset Management (1.2M shares, $14.9M), Izzy Englander's Millennium Management (967K shares, $12.3M), Cliff Asness's AQR Capital Management (883K shares, $11.3M), Ken Griffin's Citadel Advisors (196K shares, $2.5M), Two Sigma Investments (29K shares, $368K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.